Bone density results come down to one key number: your T-score. This score compares your bone density to that of a healthy 30-year-old adult at peak bone mass. A T-score of -1 or higher means your bones are healthy. Between -1 and -2.5 indicates osteopenia, a milder form of bone loss. A T-score of -2.5 or lower points to osteoporosis. Understanding where you fall on this scale, and what factors can skew the results, helps you have a much more productive conversation about next steps.
What Your T-Score Means
Your bone density report will list T-scores for each site that was measured. The number represents how far your bone density falls above or below the average for a young, healthy adult. Each full point on the scale equals one standard deviation, a statistical unit of difference. So a T-score of -2.0 means your bone density is two standard deviations below that healthy baseline.
The three categories, established by the World Health Organization, break down like this:
- Normal (T-score of -1.0 or higher): Your bone density is within the expected healthy range.
- Osteopenia (T-score between -1.0 and -2.5): You have lower-than-normal bone density, but not enough loss to qualify as osteoporosis. This is sometimes called “low bone mass.”
- Osteoporosis (T-score of -2.5 or lower): Bone loss is significant enough that your fracture risk is meaningfully elevated.
A T-score of -1.5 and a T-score of -2.4 both fall in the osteopenia range, but they carry very different levels of risk. The further your score dips toward -2.5, the more seriously your doctor will weigh treatment options. Someone with a T-score right at the border often needs additional risk assessment before deciding on medication.
Why Your Report Shows Multiple Scores
A standard DXA scan measures bone density at the lumbar spine (lower back) and the hip, typically reporting separate scores for the femoral neck and total hip. These sites are chosen because they’re the most clinically useful. Hip bone density is the single best predictor of hip fracture risk, with large studies showing that each standard deviation of bone loss at the hip roughly doubles to triples the risk of a hip fracture. Spine measurements, meanwhile, are better for tracking changes over time because the spine responds to treatment faster than the hip does.
Your T-scores at different sites won’t always match. It’s common to have normal density at the hip but osteopenia at the spine, or vice versa. When your scores diverge like this, the lowest T-score among the measured sites is generally the one used for diagnosis. If your spine reads -1.8 but your hip reads -0.7, you’d be classified in the osteopenia range based on the spine result.
T-Score vs. Z-Score
Your report may also include a Z-score, which compares your bone density to other people your same age, sex, and body size rather than to a 30-year-old. The Z-score matters most for younger adults, premenopausal women, and men under 50, because the T-score comparison to peak bone mass isn’t as meaningful when you haven’t yet reached the age where significant bone loss is expected.
A Z-score of -2.0 or lower is a red flag that something beyond normal aging may be driving bone loss. This could point to an underlying condition like a thyroid disorder, vitamin D deficiency, celiac disease, or a medication side effect. When a Z-score drops that low, expect your doctor to order additional bloodwork to look for a treatable cause.
Things That Can Throw Off Your Results
DXA scans measure density by sending two X-ray beams through bone and calculating how much energy gets absorbed. Anything dense that sits in the scan’s path can artificially inflate your score. Spinal arthritis is one of the most common culprits: the extra bone growth from degenerative changes in the vertebrae gets read as denser bone, potentially masking osteoporosis. Surgical hardware, spinal cord stimulators, pacemakers, and even aortic calcifications can all push spine measurements higher than they truly are.
If you have known arthritis in your lower back or any implanted devices near the scan sites, make sure your technician and doctor are aware. In some cases, individual vertebrae that are clearly affected by artifacts will be excluded from the calculation, or the diagnosis will rely more heavily on the hip measurement instead. A falsely reassuring spine score in someone with significant spinal arthritis is a well-documented pitfall.
How Fracture Risk Goes Beyond the T-Score
Your T-score alone doesn’t determine whether you need medication. A tool called FRAX calculates your 10-year probability of a major osteoporotic fracture by combining your femoral neck bone density with other risk factors: your age, sex, weight, smoking status, alcohol use, history of previous fractures, family history of hip fracture, and whether you take corticosteroids. FRAX can even estimate fracture risk without a bone density measurement at all, though adding the DXA result makes it more accurate.
Treatment decisions in the osteopenia range often hinge on this calculation. Someone with a T-score of -1.8 and no other risk factors faces a very different situation than someone with that same score who smokes, takes steroids, and has a parent who broke a hip. When spine and hip T-scores disagree significantly, a commonly used adjustment increases or decreases the FRAX estimate by about 10% for each full T-score point of difference between the two sites.
A previous fragility fracture, one that happened from a fall at standing height or less, is itself considered strong grounds for treatment regardless of what the T-score shows. Bones that have already broken once under minimal force are at substantially higher risk of breaking again.
Comparing Scans Over Time
If you’ve had more than one DXA scan, you’ll naturally want to compare the numbers. But not every change between scans is meaningful. DXA machines have a small margin of measurement error, and the concept of the “least significant change” tells you how much the number needs to shift before you can be confident it reflects real bone loss or gain rather than normal machine variability.
For most people, a change of at least 0.03 g/cm² in bone mineral density is considered significant. Below that threshold, the difference could simply be measurement noise. For people with stage 2 or stage 3 obesity, the margin is wider, around 0.05 g/cm², because body size can affect scan precision. Your report may express changes as a percentage, but the same principle applies: a 1% shift is likely within the margin of error, while a 3% to 5% change over two years is more likely to be real.
This is one reason follow-up scans aren’t typically done sooner than two years after the initial test. Most guidelines recommend repeating a DXA every two years for monitoring, and every one to two years for people who have started osteoporosis medication. Scanning more frequently than every two years rarely produces clinically useful information, because bone changes slowly enough that the measurement error can obscure genuine trends over shorter intervals.
What the Scores Typically Lead To
A normal T-score with no significant risk factors generally means no treatment is needed and your next scan may be several years away. In the osteopenia range, the response depends heavily on how close you are to -2.5 and what your overall fracture risk looks like. For many people with mild osteopenia, the plan focuses on weight-bearing exercise, adequate calcium and vitamin D intake, and lifestyle changes like quitting smoking or reducing alcohol.
A T-score at or below -2.5, or a high FRAX-calculated fracture probability, typically triggers a conversation about bone-building or bone-preserving medications. These work through different mechanisms: some slow down the natural breakdown of old bone, while others stimulate the formation of new bone. The choice depends on the severity of bone loss, fracture history, and individual health factors. People on medication can expect follow-up DXA scans every one to two years to check whether bone density is stabilizing or improving, with spine measurements being particularly useful for tracking treatment response.